A genotype-directed phase I-IV dose-finding study of irinotecan in combination with fluorouracil/leucovorin as first-line treatment in advanced colorectal cancer. British journal of cancer. 2011;105(1):53-7.
Validation of a DNA methylation microarray for 450,000 CpG sites in the human genome. Epigenetics : official journal of the DNA Methylation Society. 2011;6(6).
High risk of colorectal and endometrial cancer in Ashkenazi families with the MSH2 A636P founder mutation. Gastroenterology. 2011;140(7):1919-26.
The use of caspase inhibitors in pulsed-field gel electrophoresis may improve the estimation of radiation-induced DNA repair and apoptosis. Radiation oncology (London, England). 2011;6(1):6.
Gene Expression Signature to Improve Prognosis Prediction of Stage II and III Colorectal Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2011;29(1):17-24.
No association between germline allele-specific expression of TGFBR1 and colorectal cancer risk in Caucasian and Ashkenazi populations. British journal of cancer. 2011;104(4):735-40.
Pharmacogenetic study in rectal cancer patients treated with preoperative chemoradiotherapy: polymorphisms in thymidylate synthase, epidermal growth factor receptor, GSTP1, and DNA repair genes. International journal of radiation oncology, biology, physics. 2011;81(5):1319-27.
Gene expression differences between colon and rectum tumors. Clinical cancer research : an official journal of the American Association for Cancer Research. 2011;17(23):7303-12.